8-K: Cycurion Amends iQSTEL Deal, Boosts Share Authorization
Corporate Update
Cycurion, Inc. announced amendments to its stock-for-stock exchange agreement with iQSTEL, extended timelines, and increased its authorized common stock and equity incentive plan shares following stockholder approval.
Summary
- Amended the Stock-for-Stock Exchange Agreement with iQSTEL, Inc., dated September 2, 2025.
- The amendment provides flexibility for both Cycurion and iQSTEL to satisfy a $500,000 dividend obligation to their respective shareholders by distributing either up to 50% of the shares received from the other party or an equivalent value of their own authorized common stock.
- The timeline for the issuance and delivery of shares (Closing) has been extended from 30 to 60 business days following the Original Agreement's effective date of September 2, 2025.
- A firm deadline of December 15, 2025, has been set for completing all necessary regulatory filings to facilitate the dividend distribution by December 31, 2025.
- Cycurion will issue 3,866,976 shares of its common stock to iQSTEL, and iQSTEL will issue 151,058 shares of its common stock to Cycurion, with each exchange valued at $1,000,000.
- Stockholders approved an increase in authorized common stock from 100,000,000 to 300,000,000 shares.
- Stockholders approved the ability to effect one or more reverse stock splits at a ratio between 3:1 and 75:1, and in aggregate not more than 250:1.
- The number of authorized shares under the 2025 Equity Incentive Plan was increased from 10,000,000 to 25,000,000 shares.
- Six directors were elected to the board until the 2026 annual meeting.
- WWC, P.C. was ratified as the independent registered public accounting firm for fiscal year 2025.
Sentiment
Score: 6
Explanation: The filing primarily details procedural amendments and corporate governance updates. The flexibility in dividend distribution and increased authorized shares are positive for corporate strategy, but the extended timeline for the stock exchange and the potential for dilution from increased authorized shares introduce minor neutral/negative aspects.
Positives
- Increased flexibility in dividend distribution for both Cycurion and iQSTEL, allowing retention of exchanged shares if own stock is used for dividends.
- Stockholder approval of key corporate actions, including director elections and auditor ratification, indicates stable governance.
- Increased authorized shares under the 2025 Equity Incentive Plan provides more flexibility for employee incentives and retention.
Negatives
- The extension of the closing timeline for the stock-for-stock exchange from 30 to 60 business days could indicate minor operational or administrative delays.
- The significant increase in authorized common stock from 100,000,000 to 300,000,000 shares, coupled with the authority for reverse stock splits, suggests potential for future dilution or a need to manage share price.
Risks
- Potential for dilution from the increased authorized common stock and the ability to effect reverse stock splits.
- Compliance with federal and state securities laws and Nasdaq listing rules for dividend distribution.
- Failure to complete necessary regulatory filings by December 15, 2025, could delay the dividend distribution.
Future Outlook
The company has set firm deadlines for regulatory filings and dividend distribution related to the iQSTEL stock exchange, aiming for completion by December 31, 2025. The increased authorized shares and ability to perform reverse stock splits provide future flexibility for capital management and potential strategic actions.
Management Comments
- Each Party shall cooperate with the other Party to distribute a dividend with an equivalent value of Five Hundred Thousand U.S. Dollars ($500,000) to its respective shareholders.
- Each Party shall use commercially reasonable efforts to complete all necessary regulatory filings, including SEC Filings, FINRA submissions, and Nasdaq notifications, by December 15, 2025, to facilitate the dividend distribution.
Industry Context
The stock-for-stock exchange and subsequent dividend distribution reflect a strategic partnership between Cycurion and iQSTEL, potentially aimed at strengthening ties or expanding market reach through cross-ownership and shareholder engagement. The increase in authorized shares and reverse stock split authority are common corporate actions taken by companies to manage their capital structure, often in anticipation of future financing, M&A activities, or to meet listing requirements.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | L. Kevin Kelly | 2025-09-29 | Elected by Majority Consenting Stockholders. |
| Director | NA | Emmit McHenry | 2025-09-29 | Elected by Majority Consenting Stockholders. |
| Director | NA | Peter Ginsberg | 2025-09-29 | Elected by Majority Consenting Stockholders. |
| Director | NA | Reginald S. Bailey, Sr. | 2025-09-29 | Elected by Majority Consenting Stockholders. |
| Director | NA | Kevin E. OBrien | 2025-09-29 | Elected by Majority Consenting Stockholders. |
| Director | NA | Irving Minnaker | 2025-09-29 | Elected by Majority Consenting Stockholders. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Increased the number of authorized shares of common stock from 100,000,000 to 300,000,000 shares. | 2025-09-29 | Provides greater flexibility for future equity financing, acquisitions, or other corporate purposes, but also increases potential for dilution. |
| Amendment to Certificate of Incorporation | Allows the company to effect one or more reverse stock splits at a ratio ranging between 3:1 to 75:1 and in the aggregate not more than 250:1. | 2025-09-29 | Grants management a tool to potentially increase share price, which can help meet listing requirements or improve market perception, but does not change underlying company value. |
| Equity Incentive Plan Amendment | Increased the number of authorized shares issuable under the 2025 Equity Incentive Plan from 10,000,000 to 25,000,000 shares of common stock. | 2025-09-29 | Enhances the company's ability to attract and retain talent through equity compensation, but could lead to increased share-based compensation expense and potential dilution. |
| Auditor Ratification | Ratified the appointment of WWC, P.C. as the company's independent registered public accounting firm for fiscal year 2025. | 2025-09-29 | Standard corporate governance practice, ensuring independent oversight of financial reporting. |
| Advisory Vote on Executive Compensation | Approved, on an advisory, non-binding basis, the compensation of named executive officers. | 2025-09-29 | Reflects shareholder input on executive pay, aligning with best practices in corporate governance. |
| Advisory Vote on Executive Compensation Frequency | Recommended, on a non-binding basis, a one-year frequency of future advisory votes on compensation of named executive officers. | 2025-09-29 | Indicates a preference for annual shareholder review of executive compensation, promoting accountability. |
Stakeholder Impact
- Shareholders: Will receive a $500,000 dividend (either in iQSTEL shares, Cycurion shares, or a combination). Potential for dilution due to increased authorized shares and equity incentive plan. Potential for share price adjustment if a reverse stock split is enacted.
- Management/Employees: Benefit from the increased shares available under the 2025 Equity Incentive Plan, enhancing compensation and retention.
- iQSTEL: Gains flexibility in its dividend distribution and confirms its ownership stake in Cycurion.
Next Steps
- Complete the issuance and delivery of shares for the stock-for-stock exchange within 60 business days following September 2, 2025.
- Complete all necessary regulatory filings (SEC, FINRA, Nasdaq) by December 15, 2025, to facilitate the dividend distribution.
- Complete the $500,000 dividend distribution to shareholders by December 31, 2025.
- The newly elected directors will serve until the annual meeting of stockholders in 2026.
Key Dates
| Date | Description |
|---|---|
| 2025-08-13 | Record Date for Majority Consenting Stockholders' vote. |
| 2025-08-28 | Majority Consenting Stockholders approved certain actions by written consent; Preliminary Information Statement on Schedule 14C filed. |
| 2025-09-02 | Effective Date of the Original Stock-for-Stock Exchange Agreement with iQSTEL, Inc. |
| 2025-09-09 | Definitive Information Statement on Schedule 14C mailed to stockholders. |
| 2025-09-26 | Date of First Amendment to Stock-for-Stock Exchange Agreement with iQSTEL, Inc. |
| 2025-09-29 | Charter Amendment filed with Delaware Secretary of State; Effective date for matters approved by Majority Consenting Stockholders. |
| 2025-12-15 | Firm deadline for completing all necessary regulatory filings to facilitate dividend distribution. |
| 2025-12-31 | Firm deadline for completing dividend distribution. |
| 2026 | Annual meeting of stockholders where elected directors will serve until. |
Recommendation
holdThe filing outlines several strategic and governance updates rather than immediate operational or financial performance results. The amendments to the iQSTEL stock exchange agreement provide operational flexibility, and the increase in authorized shares and reverse stock split authority are tools for future capital management. While these actions are generally positive for long-term strategic flexibility, they do not immediately signal a strong buy or sell. The extended timeline for the stock exchange and the potential for future dilution warrant a cautious 'hold' stance, awaiting further clarity on the company's strategic use of its expanded capital structure and the impact of the dividend distribution.
Keywords
Cycurion, CYCU, iQSTEL, Stock Exchange Agreement, Dividend, Authorized Shares, Reverse Stock Split, Equity Incentive Plan, Corporate Governance, SEC Filing, NASDAQ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.